RICHMOND, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge", “the Company”), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of ...

The company received A+ for growth and profitability ... driven by strong revenue growth in its GLP-1 tirzepatide franchise - ...

putting compounding of tirzepatide into a gray area. Meanwhile, semaglutide remains on the shortages list, but Novo Nordisk ...

When starting prescription weight loss medications, getting approval from a doctor and insurance is one of the hardest parts.

Lord Vallance stated the government sees investment, innovation, and public-private partnership as crucial to UK healthcare.

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

Shares of Viking Therapeutics (NASDAQ: VKTX) fell on Monday, Nov. 4, despite some encouraging new data. Over the weekend, the ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...